PDGF enhances orbital fibroblast responses to TSHR stimulating autoantibodies in Graves' ophthalmopathy patients

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 6, 2012, Pages

  Van Steensel, L ^a   Hooijkaas, H ^a   Paridaens, D ^a,b,c   Van Den Bosch, W A ^b   Kuijpers, R W A M ^a   Drexhage, H A ^a   Van Hagen, P M ^a   Dik, Willem A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ROTTERDAM EYE HOSPITAL   (Netherlands)

^c Geneva General Hospital   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; IMMUNOGLOBULIN; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR AB; PLATELET DERIVED GROWTH FACTOR BB; RANTES; THYROID ANTIBODY; THYROTROPIN; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY;

ARTICLE; CELL ACTIVITY; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOCRINE OPHTHALMOPATHY; ENZYME ACTIVATION; FIBROBLAST; HORMONE ACTION; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; ORBIT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION;

AUTOANTIBODIES; CELLS, CULTURED; CYCLIC AMP; FIBROBLASTS; GRAVES OPHTHALMOPATHY; HUMANS; HYALURONIC ACID; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, THYROID-STIMULATING; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-6; ORBIT; PLATELET-DERIVED GROWTH FACTOR; PROTO-ONCOGENE PROTEINS C-SIS; RECEPTOR, IGF TYPE 1; RECEPTORS, THYROTROPIN; SIGNAL TRANSDUCTION; THYROTROPIN;

BOVINAE;

EID: 84861986767     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-1020     Document Type: Article

References (40)

1. Bahn RS 2010 Graves' ophthalmopathy. N Engl J Med 362:726-738
2. Hegedus L, Smith TJ, Douglas RS, Nielsen CH 2011 Targeted biological therapies for Graves' disease and thyroid-associated ophthalmopathy. Focus on B-cell depletion with Rituximab. Clin Endocrinol (Oxf) 74:1-8
3. Paridaens D, van den Bosch WA, van der Loos TL, Krenning EP, van Hagen PM 2005 The effect of etanercept on Graves' ophthalmopathy: a pilot study. Eye (Lond) 19:1286-1289 (Pubitemid 43148503)
4. van Steensel L, Dik WA 2010 The orbital fibroblast: a key player and target for therapy in Graves' ophthalmopathy. Orbit 29:202-206
5. Smith TJ, Tsai CC, Shih MJ, Tsui S, Chen B, Han R, Naik V, King CS, Press C, Kamat S, Goldberg RA, Phipps RP, Douglas RS, Gianoukakis AG 2008 Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy. Thyroid 18:983-988
6. Khoo TK, Bahn RS 2007 Pathogenesis of Graves' ophthalmopathy: the role of autoantibodies. Thyroid 17:1013-1018 (Pubitemid 350071598)
7. Wiersinga WM 2011 Autoimmunity in Graves' ophthalmopathy: the result of an unfortunate marriage between TSH receptors and IGF-1 receptors? J Clin Endocrinol Metab 96:2386-2394
8. Bahn RS, Dutton CM, Joba W, Heufelder AE 1998 Thyrotropin receptor expression in cultured Graves' orbital preadipocyte fibroblasts is stimulated by thyrotropin. Thyroid 8:193-196 (Pubitemid 28103609)
9. Bahn RS, Dutton CM, Natt N, Joba W, Spitzweg C, Heufelder AE 1998 Thyrotropin receptor expression in Graves' orbital adipose/ connective tissues: potential autoantigen in Graves' ophthalmopathy. J Clin Endocrinol Metab 83:998-1002 (Pubitemid 28496482)
10. Boschi A, Daumerie Ch, Spiritus M, Beguin C, Senou M, Yuksel D, Duplicy M, Costagliola S, Ludgate M, Many MC 2005 Quantification of cells expressing the thyrotropin receptor in extraocular muscles in thyroid associated orbitopathy. Br J Ophthalmol 89: 724-729 (Pubitemid 40780581)
11. Stadlmayr W, Spitzweg C, Bichlmair AM, Heufelder AE 1997 TSH receptor transcripts and TSH receptor-like immunoreactivity in orbital and pretibial fibroblasts of patients with Graves' ophthalmopathy and pretibial myxedema. Thyroid 7:3-12 (Pubitemid 27132889)
12. Zhang L, Baker G, Janus D, Paddon CA, Fuhrer D, Ludgate M 2006 Biological effects of thyrotropin receptor activation on human orbital preadipocytes. Invest Ophthalmol Vis Sci 47:5197-5203 (Pubitemid 46723765)
13. Zhang L, Bowen T, Grennan-Jones F, Paddon C, Giles P, Webber J, Steadman R, Ludgate M 2009 Thyrotropin receptor activation increases hyaluronan production in preadipocyte fibroblasts: contributory role in hyaluronan accumulation in thyroid dysfunction. J Biol Chem 284:26447-26455
14. Kumar S, Schiefer R, Coenen MJ, Bahn RS 2010 A stimulatory thyrotropin receptor antibody (M22) and thyrotropin increase interleukin-6 expression and secretion in Graves' orbital preadipocyte fibroblasts. Thyroid 20:59-65
15. Gerding MN, van der Meer JW, Broenink M, Bakker O, Wiersinga WM, Prummel MF 2000 Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy. Clin Endocrinol (Oxf) 52:267-271 (Pubitemid 30169681)
16. Wakelkamp IM, Bakker O, Baldeschi L, Wiersinga WM, Prummel MF 2003 TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients. Clin Endocrinol (Oxf) 58:280-287 (Pubitemid 36308115)
17. Bonner JC 2004 Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev 15:255-273 (Pubitemid 38781050)
18. van Steensel L, Paridaens D, Schrijver B, Dingjan GM, van Daele PL, van Hagen PM, van den Bosch WA, Drexhage HA, Hooijkaas H, Dik WA 2009 Imatinib mesylate and AMN107 inhibit PDGF-signaling in orbital fibroblasts: a potential treatment for Graves' ophthalmopathy. Invest Ophthalmol Vis Sci 50:3091-3098
19. van Steensel L, Hooijkaas H, van Meurs M, Paridaens D, van den Bosch WA, Kuijpers RW, Van Hagen PM, Drexhage HA, Dik WA 2012 Orbit-infiltrating mast cells, monocytes and macrophages produce PDGF isoforms that orchestrate orbital fibroblast activation in Graves' Ophthalmopathy. J Clin Endocrinol Metab 97:E400-E408
20. van Steensel L, Paridaens D, Dingjan GM, van Daele PL, van Hagen PM, Kuijpers RW, van den Bosch WA, Drexhage HA, Hooijkaas H, Dik WA 2010 Platelet-derived growth factor-BB: a stimulus for cytokine production by orbital fibroblasts in Graves' ophthalmopathy. Invest Ophthalmol Vis Sci 51:1002-1007
21. Evans M, Sanders J, Tagami T, Sanders P, Young S, Roberts E, Wilmot J, Hu X, Kabelis K, Clark J, Holl S, Richards T, Collyer A, Furmaniak J, Smith BR 2010 Monoclonal autoantibodies to the TSH receptor, one with stimulating activity and one with blocking activity, obtained from the same blood sample. Clin Endocrinol (Oxf) 73:404-412
22. Latif R, Morshed SA, Zaidi M, Davies TF 2009 The thyroid-stimulating hormone receptor: impact of thyroid-stimulating hormone and thyroid-stimulating hormone receptor antibodies on multimerization, cleavage, and signaling. Endocrinol Metab Clin North Am 38:319-341, viii
23. Pritchard J, Han R, Horst N, Cruikshank WW, Smith TJ 2003 Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the insulin-like growth factor I receptor pathway. J Immunol 170: 6348-6354 (Pubitemid 36682621)
24. Valyasevi RW, Erickson DZ, Harteneck DA, Dutton CM, Heufelder AE, Jyonouchi SC, Bahn RS 1999 Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor. J Clin Endocrinol Metab 84:2557-2562
25. Valyasevi RW, Harteneck DA, Dutton CM, Bahn RS 2002 Stimulation of adipogenesis, peroxisome proliferator-activated receptor-γ(PPARγ), and thyrotropin receptor by PPARγ agonist in human orbital preadipocyte fibroblasts. J Clin Endocrinol Metab 87:2352-2358 (Pubitemid 34521530)
26. Valyasevi RW, Jyonouchi SC, Dutton CM, Munsakul N, Bahn RS 2001 Effect of tumor necrosis factor-α, interferon-γ, and transforming growth factor-β on adipogenesis and expression of thyrotropin receptor in human orbital preadipocyte fibroblasts. J Clin Endocrinol Metab 86:903-908 (Pubitemid 32207513)
27. van Steensel L, van Hagen PM, Paridaens D, Kuijpers RW, van den Bosch WA, Drexhage HA, Hooijkaas H, Dik WA 2011 Whole orbital tissue culture identifies imatinib mesylate and adalimumab as potential therapeutics for Graves' ophthalmopathy. Br J Ophthalmol 95:735-738
28. Bachmeier M, Löffler G 1995 Influence of growth factors on growth and differentiation of 3T3-L1 preadipocytes in serum-free conditions. Eur J Cell Biol 68:323-329
29. Krieger-Brauer HI, Kather H 1995 Antagonistic effects of different members of the fibroblast and platelet-derived growth factor families on adipose conversion and NADPH-dependent H2O2 generation in 3T3-L1-cells. Biochem J 307(Pt 2):549-556
30. Molgat AS, Gagnon A, Sorisky A 2009 Preadipocyte apoptosis is prevented by macrophage-conditioned medium in a PDGF-dependent manner. Am J Physiol Cell Physiol 296:C757-C765
31. van Zeijl CJ, Fliers E, van Koppen CJ, Surovtseva OV, de Gooyer ME, Mourits MP, Wiersinga WM, Miltenburg AM, Boelen A 2011 Thyrotropin receptor-stimulating Graves' disease immunoglobulins induce hyaluronan synthesis by differentiated orbital fibroblasts from patients with Graves' ophthalmopathy not only via cyclic adenosine monophosphate signaling pathways. Thyroid 21:169-176
32. Heufelder AE, Bahn RS 1994 Modulation of Graves' orbital fibroblast proliferation by cytokines and glucocorticoid receptor agonists. Invest Ophthalmol Vis Sci 35:120-127 (Pubitemid 24046834)
33. Hirano T 1998 Interleukin 6 and its receptor: ten years later. Int Rev Immunol 16:249-284 (Pubitemid 28102256)
34. Rotondi M, Chiovato L, Romagnani S, Serio M, Romagnani P 2007 Role of chemokines in endocrine autoimmune diseases. Endocr Rev 28:492-520 (Pubitemid 47236335)
35. Pappa A, Lawson JM, Calder V, Fells P, Lightman S 2000Tcells and fibroblasts in affected extraocular muscles in early and late thyroid associated ophthalmopathy. Br J Ophthalmol 84:517-522 (Pubitemid 30251714)
36. Laurent E, Van Sande J, Ludgate M, Corvilain B, Rocmans P, Dumont JE, Mockel J 1991 Unlike thyrotropin, thyroid-stimulating antibodies do not activate phospholipase C in human thyroid slices. J Clin Invest 87:1634-1642
37. Drexhage HA 1996 Autoimmunity and thyroid growth. Where do we stand? Eur J Endocrinol 135:39-45 (Pubitemid 26232705)
38. Kumar S, Nadeem S, Stan MN, Coenen M, Bahn RS 2011 A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy. J Mol Endocrinol 46:155-163
39. Ponto KA, Kanitz M, Olivo PD, Pitz S, Pfeiffer N, Kahaly GJ 2011 Clinical relevance of thyroid-stimulating immunoglobulins in Graves' ophthalmopathy. Ophthalmology 118:2279-2285
40. van Zeijl CJ, Fliers E, van Koppen CJ, Surovtseva OV, de Gooyer ME, Mourits MP, Wiersinga WM, Miltenburg AM, Boelen A 2010 Effects of thyrotropin and thyrotropin-receptor-stimulating Graves'disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients. Thyroid 20:535-544